Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Aurinia Pharmaceuticals Inc (NASDAQ: AUPH).

Full DD Report for AUPH

You must become a subscriber to view this report.


Recent News from (NASDAQ: AUPH)

Free Stock Performance Review on Array BioPharma and Three More Biotech Industry
Stock Research Monitor: ITCI, ARGS, and AUPH LONDON, UK / ACCESSWIRE / May 16, 2018 / If you want a free Stock Review on ARRY sign up now at www.wallstequities.com/registration . On Tuesday, the NASDAQ Composite ended the day at 7,351.63, down 0.81%; the Dow Jones Industrial Average ed...
Source: ACCESSWIRE IA
Date: May, 16 2018 07:05
Aurinia Pharmaceuticals' (AUPH) CEO Richard Glickman on Q1 2018 Results - Earnings Call Transcript
Aurinia Pharmaceuticals Inc. (AUPH) Q1 2018 Earnings Conference Call May 10, 2018, 04:30 PM ET Executives Celia Economides - VP, Corporate and Public Affairs Richard Glickman - CEO and Chairman Dennis Bourgeault - CFO Neil Solomons - CMO Analysts Joseph Schwartz - Leerink...
Source: SeekingAlpha
Date: May, 10 2018 21:33
Aurinia Pharma misses by $0.02, misses on revenue
Aurinia Pharma (NASDAQ: AUPH ): Q1 EPS of -$0.18 misses by $0.02 . Revenue of $0.03M (flat Y/Y) misses by $0.02M . Press Release More news on: Aurinia Pharmaceuticals Inc., Earnings news and commentary, Healthcare stocks news,
Source: SeekingAlpha
Date: May, 10 2018 16:26
Aurinia Reports First Quarter Financial Results and Operational Highlights
AURORA Phase III Trial in lupus nephritis remains on track Trials in FSGS and Dry Eye expected to begin in June 2018 Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (“Aurinia” or the “Company”) has released its financial results for the first quar...
Source: Business Wire
Date: May, 10 2018 16:02
Aurinia Pharmaceuticals Recognizes World Lupus DayTM with Activities Focused on Raising Awareness of Lupus Nephritis
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH/TSX:AUP), a clinical stage biopharmaceutical company focused on the global immunology market, today announced its support for World Lupus Day TM with activities focused on raising awareness of lupus nephritis (LN). In honor of the day, Aurinia is co...
Source: Business Wire
Date: May, 10 2018 08:00
Aurinia Pharmaceuticals (AUPH) Presents At 2018 Bloom Burton & Co. Healthcare Investor Conference - Slideshow
The following slide deck was published by Aurinia Pharmaceuticals Inc. in conjunction with this Read more ...
Source: SeekingAlpha
Date: May, 04 2018 14:54
Lucky Seven: An Introduction To My Top Biotechnology Picks
Introduction I am a Registered Nurse, currently advancing my education at Purdue University. I work on an intermediate care unit in a hospital where I am responsible for the care and lives of folks who come to me with a myriad of medical conditions. I hope to soon become a nursing professor....
Source: SeekingAlpha
Date: May, 03 2018 05:28
Aurinia Pharmaceuticals to Release First Quarter 2018 Financial Results on May 10, 2018
Conference Call and webcast to follow Aurinia Pharmaceuticals Inc., (NASDAQ: AUPH / TSX: AUP) today announced that it will release its first quarter 2018 financial results on Thursday, May 10, 2018, after the market closes. Aurinia’s management will host a conference call to...
Source: Business Wire
Date: May, 01 2018 16:23
Aurinia to Present at the Bloom Burton & Co. Healthcare Investor Conference on May 3, 2018
Aurinia Pharmaceuticals Inc., (NASDAQ:AUPH)(TSX:AUP) today announced that Celia Economides, Vice President, Corporate and Public Affairs, will present at the Bloom Burton & Co. Healthcare Investor Conference on Thursday, May 3 rd at 1:30pm EDT. A webcast will be available and can be acc...
Source: Business Wire
Date: April, 25 2018 16:01
Aurinia Pharma (AUPH) Presents At H. C. Wainwright Global Life Sciences Conference - Slideshow
The following slide deck was published by Aurinia Pharmaceuticals Inc. in conjunction with this Read more ...
Source: SeekingAlpha
Date: April, 11 2018 12:57

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-245.815.855.915.79292,673
2018-05-235.785.825.995.75349,330
2018-05-225.805.825.995.73423,097
2018-05-216.105.7856.165.72738,688
2018-05-186.116.076.246.00715,399

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-05-2446,451137,96033.6699Cover
2018-05-2340,809153,60226.5680Cover
2018-05-2283,361214,03538.9474Short
2018-05-21121,806356,68134.1498Cover
2018-05-18196,264457,91342.8605Short

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on AUPH.


About Aurinia Pharmaceuticals Inc (NASDAQ: AUPH)

Logo for Aurinia Pharmaceuticals Inc (NASDAQ: AUPH)

Not available

 

Contact Information

 

 

Current Management

  • Stephen W. Zaruby / President, CEO
  • Launa Aspeslet / COO

Current Share Structure

     


    Recent Filings from (NASDAQ: AUPH)

    Amendment to a previously filed 6-K
    Filing Type: 6-K/AFiling Source: edgar
    Filing Date: May, 17 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: May, 16 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: May, 10 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: May, 10 2018
    Voluntary supplemental materials filed by foreign issuers under Section 11(a) of the 1933 Act
    Filing Type: SUPPLFiling Source: edgar
    Filing Date: April, 06 2018
    Amendment to a previously filed F-10
    Filing Type: F-10/AFiling Source: edgar
    Filing Date: March, 26 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: March, 15 2018
    Registration of a class of securities of certain Canadian issuers under Section 12(b) of the 1934 Act
    Filing Type: 40-FFiling Source: edgar
    Filing Date: March, 15 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: February, 23 2018
    Statement of beneficial ownership of common stock by certain persons
    Filing Type: SC 13GFiling Source: edgar
    Filing Date: February, 13 2018

     

     


    Daily Technical Chart for (NASDAQ: AUPH)

    Daily Technical Chart for (NASDAQ: AUPH)


    Stay tuned for daily updates and more on (NASDAQ: AUPH)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (NASDAQ: AUPH)

    Do your DD and if you choose, be ready to go!


     

    The Research: All source information contained in this email is from the public sources mentioned below.

     

     
     

    Thank you

    The Subway Trader
    @TheSubwayTrader

     

     


    Disclaimer: The Subway Trader publishes reports providing information on selected companies. The Subway Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. The Subway Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in AUPH is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. The Subway Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. The Subway Trader does not own any shares of AUPH and does not buy, sell, or trade any shares of AUPH. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by The Subway Trader. All rights reserved. Our Full Disclaimer: http://thesubwaytrader.com/disclaimer/